Know your Atrial Fibrillation (AFib) Treatment Options

Know Your Medication Options

When you have AFib, your risk of stroke is nearly 5 times higher than that of someone who doesn’t have the condition. So reducing your stroke risk is an important part of treating your AFib.

The most common cause of stroke is a blood clot — a solid mass of blood that clumps together and blocks the flow of blood through an artery in or leading to your brain. When you have AFib, blood clots can form in your heart and move through your body to your brain, where they can cause a stroke.

To help prevent blood clots from forming, your doctor may prescribe:

  • An anticoagulant — a medication that reduces your blood’s ability to coagulate (or form clots) by interfering with the process of clot formation.
  • An antiplatelet — a medication that helps to reduce the ability of your blood platelets to stick together to form a clot.

As part of your treatment plan, your doctor may also address other factors such as high blood pressure, diabetes, or a history of previous stroke or TIA (“mini stroke” or transient ischemic attack).

If you have been diagnosed with AFib, don’t wait. Talk to your doctor about how to help reduce your stroke risk today. Only you and your doctor can determine the treatment plan that is right for you.

Build a personalized doctor discussion guide now >

Please Note: You are now leaving a Boehringer Ingelheim Pharmaceuticals, Inc. site. Boehringer Ingelheim Pharmaceuticals, Inc. has not reviewed the contents of all the pages and sites that may be linked to this site. Boehringer Ingelheim Pharmaceuticals, Inc. is not responsible and disclaims any liability to the content of any other page or site or for any viruses or similar harmful programs that may be present on such pages or sites. Linking to any other page or site is at your own risk.
Submit
Close X
Please Note: You are now leaving a Boehringer Ingelheim Pharmaceuticals, Inc. site. Boehringer Ingelheim Pharmaceuticals, Inc. has not reviewed the contents of all the pages and sites that may be linked to this site. Boehringer Ingelheim Pharmaceuticals, Inc. is not responsible and disclaims any liability to the content of any other page or site or for any viruses or similar harmful programs that may be present on such pages or sites. Linking to any other page or site is at your own risk.
Submit
Close X
Please Note: You are now leaving a Boehringer Ingelheim Pharmaceuticals, Inc. site. Boehringer Ingelheim Pharmaceuticals, Inc. has not reviewed the contents of all the pages and sites that may be linked to this site. Boehringer Ingelheim Pharmaceuticals, Inc. is not responsible and disclaims any liability to the content of any other page or site or for any viruses or similar harmful programs that may be present on such pages or sites. Linking to any other page or site is at your own risk.
Submit
Close X
Please Note: You are now leaving a Boehringer Ingelheim Pharmaceuticals, Inc. site. Boehringer Ingelheim Pharmaceuticals, Inc. has not reviewed the contents of all the pages and sites that may be linked to this site. Boehringer Ingelheim Pharmaceuticals, Inc. is not responsible and disclaims any liability to the content of any other page or site or for any viruses or similar harmful programs that may be present on such pages or sites. Linking to any other page or site is at your own risk.
Submit
Close X
Please Note: You are now leaving a Boehringer Ingelheim Pharmaceuticals, Inc. site. Boehringer Ingelheim Pharmaceuticals, Inc. has not reviewed the contents of all the pages and sites that may be linked to this site. Boehringer Ingelheim Pharmaceuticals, Inc. is not responsible and disclaims any liability to the content of any other page or site or for any viruses or similar harmful programs that may be present on such pages or sites. Linking to any other page or site is at your own risk.
Submit
Close X

Share with a friend

If you would like to send this page to a friend, please provide the information requested below. To protect the privacy of both you and your friend, neither your nor your friend's Email address will be captured in any way. Your Email addresses will not be sold or forwarded to any other party for any other purpose, and will be accessible only by Boehringer Ingelheim Pharmaceuticals, Inc.
Your Email:*
Friend's Email:* *Required Information
Subject: I thought you might want to know about this.

I'm writing to you because there's an important connection between your heart and your head you may want to learn about. That connection involves the risk of stroke.

If you or a loved one has been diagnosed with atrial fibrillation (AFib), the risk of stroke is nearly 5 times greater than someone who doesn't have AFib. And that stroke can be twice as likely fatal or to be severely disabling.

You can read about it in a new book called, “AFib and Stroke: the Heart-Head Connection.” It tells about AFib and stroke, treatment options, and more. It's free and you can get a copy just by visiting: http://www.facingafib.com/?sc=PRDACQWEBSAFWKT1006085
Send yourself a copy? Yes No
Close X

THANK YOU

Your email has been sent.
Close X
CLOSE X